FANJ
PTLA

Financial Architects (New Jersey)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Financial Architects (New Jersey)’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-200
Closed -$5K – 1556
2018
Q3 		$5K Buy
+200
New +$6.53K ﹤0.01% 1243

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Financial Architects (New Jersey)'s PTLA Position: Q4 2018 in Review

Financial Architects (New Jersey) sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2018, closing a stake of 200 shares — an estimated $5K sold.

Financial Architects (New Jersey) first reported a position in PTLA in Q3 2018 and held it in 1 quarter. The position peaked at $5K in Q3 2018. 181 funds tracked by Wall St. Rank hold PTLA as of Q4 2018.

  • Financial Architects (New Jersey) reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 200 Portola Pharmaceuticals, Inc. shares in Q4 2018, an estimated $5K.
  • Financial Architects (New Jersey) first reported a position in Portola Pharmaceuticals, Inc. in Q3 2018 and held it in 1 quarter.
  • Financial Architects (New Jersey)'s Portola Pharmaceuticals, Inc. position peaked at $5K in Q3 2018.
  • 181 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2018.

Based on Financial Architects (New Jersey)'s 13F filing for Q4 2018, filed 1 Feb 2019.